Burris v. Andersen Corp., 012320 IAWC, 5061159

Case DateJanuary 23, 2020
CourtIowa
BEN BURRIS, Claimant
v.
ANDERSEN CORPORATION, Employer,
and
OLD REPUBLIC INSURANCE COMPANY, Insurance Carrier, Defendants.
No. 5061159
Iowa Workers Compensation
Before the Iowa Workers' Compensation Commissioner
January 23, 2020
         Head Note Nos: 1803, 2502           APPEAL DECISION           JOSEPH S. CORTESE, II WORKERS' COMPENSATION COMMISSIONER          Claimant Ben Burris appeals from an arbitration decision filed on August 30, 2018. Defendants Andersen Corporation, employer, and Old Republic Insurance Company, insurance carrier, respond to the appeal. The case was heard on October 18, 2017, and it was considered fully submitted in front of the deputy workers' compensation commissioner on November 27, 2017.          In the arbitration decision, the deputy commissioner addressed both of the affirmative defenses raised by defendants. With respect to notice, the deputy commissioner found defendants had actual notice of the toxic compounds with which claimant was required to work, along with the toxicity of those compounds. However, the deputy commissioner determined claimant failed to timely file his claim. More specifically, the deputy commissioner found claimant discovered his injury no later than January of 2007, when he proceeded with a kidney transplant. Because claimant did not file his original notice and petition within two years of his kidney transplant, the deputy commissioner found claimant's petition was untimely and barred by the statute of limitations in Iowa Code section 85.26.          On appeal, claimant asserts the deputy commissioner used the wrong legal test in her statute of limitations analysis and claimant asserts he timely filed his claim. Claimant further asserts his exposure to toxic materials while employed by defendant-employer caused his kidney condition and that he provided sufficient notice to defendants.          Those portions of the proposed agency decision pertaining to issues not raised on appeal are adopted as a part of this appeal decision.          I performed a de novo review of the evidentiary record and the detailed arguments of the parties. Pursuant to Iowa Code sections 17A.5 and 86.24, those portions of the proposed arbitration decision filed on August 30, 2018, that relate to the issues properly raised on intra-agency appeal are reversed.          FINDINGS OF FACT          Claimant began working at Eagle Window and Door (hereinafter "Eagle Window") as a painter in July of 1983 and continued to do so through November 11, 2015. (Hearing Transcript, page 62) Over the course of claimant's more than 30-year employment at Eagle Window, Eagle Window has had several owners. From the date of claimant's hire through 1987, Eagle Window was owned by Lancer Corporation; Masco Corporation purchased Eagle Window in 1987 and were the owners until the company sold to American Architectural Products in 1995; from 1995 through 2000, Eagle Window was owned by American Architectural Products; from 2000 through 2004, Eagle Window was owned by Lensalata Business Investments; and finally, from roughly 2005 through claimant's last day of work, Eagle Window was owned by Andersen Corporation - the named defendant-employer in this case (hereinafter "Andersen"). (Tr., pp. 91-92)          While Eagle Window was owned by Lancer Corporation, Masco Corporation and American Architectural Products, claimant was stationed to work at a plant on East Ninth Street in Dubuque, Iowa. (Tr., p. 68) Claimant explained that in the plant's courtyard were barrels of hazardous waste stacked 10 to 12 barrels high from the plant's previous occupants. (Tr., p. 71) At some point in the 1980s, claimant showed up to work and the barrels had been dumped into a sewer that was "right outside the lunchroom." (Tr., p. 71) Claimant also testified there were puddles of hazardous waste in the courtyard that were four inches deep. (Tr., p. 71)          During claimant's direct exposure of these chemicals, he was not provided with any protective or safety equipment or clothing. (Tr., pp. 72-73) He was eventually given a respirator in 1987. (Tr., p. 73)          In the late-1980s or early-1990s, claimant and several of his co-workers were instructed by a supervisor to attend a physical due to suspected exposures to the improperly disposed chemicals and waste. (Exhibit B, pp. 11-13; [Deposition Tr., pp. 44-46, 51]; Tr., p. 99) The physician who performed the physical, Dr. Krish, discovered blood in claimant's urine. (Ex. B, p. 12 [Depo. Tr., pp. 46]) Claimant then transferred treatment for his kidney condition to his primary care provider, John Whalen, M.D. (Def. Ex. B, pp. 13-14 [Depo. Tr., pp. 50-53])          Claimant began feeling poorly due to his kidney condition in 1994 or 1995. (Ex. B, p. 12 [Depo. Tr., p. 47]) Claimant continued various forms of conservative treatment with Dr. Whalen through the remainder of the 1990s and into the early 2000s, but he eventually required a kidney transplant in 2007. (See Joint Exhibit 1, pp. 1-11; JE 3) After the transplant, claimant returned to work at Eagle Window and continued working through November 11, 2015.          On that date, claimant's condition deteriorated to the point that he was unable to work due to excessive swelling. (Tr., p. 82) Claimant's wife transported him to the hospital, where claimant was immediately started on dialysis. (Tr., p. 83) Claimant did not return to work, and at the time of the hearing, he remained on dialysis for nine hours a day, seven days a week. (Tr., p. 86) As a result, I find November 11, 2015, was the day claimant became actually incapacitated from performing his job.          In his deposition, claimant testified he believed it was the dumping of hazardous materials from 1983 through 1987 and his continued exposure through the year 2000 at the East Ninth Street plant that caused his kidney disease. (Ex. B, p. 8 [Depo. Tr., pp. 30, 32]; Tr., p. 89) Claimant specifically denied being exposed to any sort of toxic waste or material after 2000 when Eagle Window moved to a new location on Kerper Boulevard in Dubuque after being purchased by American Architectural Products. (Ex. B, p. 8 [Depo. Tr., p. 30]          Consistent with claimant's deposition testimony is the opinion of Gregory Peterson, D.O., who was asked by claimant's attorney to address the causal relationship between claimant's work-related exposures and his kidney condition. Dr. Peterson, after evaluating claimant, reviewing his medical records, and reviewing a 1992 environmental and industrial investigation report, opined that claimant's kidney condition was the result of exposure "to the myriad of toxic substances at the work site" in the 1980s and 1990s.1 (JE 4, pp. 2-3) Dr. Peterson reaffirmed his opinion at hearing, explaining that claimant during this time was exposed to "quite significant" levels of industrial solvents, toxic substances, and volatile organic compounds, which are known to cause kidney disease. (Tr., pp. 13-14)          Like Dr. Peterson, claimant's kidney physician of more than two decades, John Whalen, M.D., also opined it was "highly likely" that claimant's membranous glomerulonephritis was secondary to his exposure to various carbons and toxic chemicals while working at Eagle Window. (JE 6)          Defendants obtained the opinion of Peter Matos, D.O. (JE 5) Dr. Matos was asked by defendants to address whether claimant's exposures from 1983-2000 to EYYC Benzene Tolvel Xlol toxic waste played any causal relationship in the development of his kidney disease. (JE 5, p. 4) Contrary to the opinions of Dr. Peterson and Dr. Whalen, Dr. Matos opined that he did not believe claimant's alleged exposures between 1983 and 2000 played any causal relationship in the development of his kidney disease. (JE 5, p. 5)          Ultimately, with respect to claimant's exposure from his date of hire through 2000, I find the causation opinions of Dr. Peterson and Dr. Whalen to be more persuasive than those of Dr. Matos. The opinions of Dr. Peterson and Dr. Whalen more closely align with the timeline and progression of claimant's exposures and the development of his kidney condition. Dr. Whalen also had the benefit of treating claimant from the onset of his kidney disease in the early 1990s through his kidney transplant and dialysis.          At hearing, claimant's testimony broadened the timeframe during which he alleged he was injuriously exposed to harmful chemicals. More specifically, he testified he had continued exposure to toxic chemicals after 2000 when Eagle Window moved to a new location on Kerper Boulevard in Dubuque after being purchased by American Architectural Products. (Tr., p. 75) Claimant testified his exposure to...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT